Franck Bourdeaut

24PUBLICATIONS
197CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsRadiation therapyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 10, 2026
DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.

|Mar 09, 2026
Prognostic factors in adult patients with medulloblastoma.

Ytel Garcilazo-Reyes, Pierre Dal Col, Franck Bielle

|Mar 02, 2026
Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations.

Jakica Ćavar Pavić, Noelle Cullinan, Marjolijn Jongmans

|Sep 17, 2025
Rare Variants Associated With Pediatric Cancer Treatment-Related Second Malignant Neoplasm Risk.

Claire Ducos, Brice Fresneau, Filippo Rosselli

|Feb 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.

Peter N Fiorica, Lisa Golmard, Jung Kim

Pageof 4